Radiopharm Theranostics (ASX:RAD) Other Current Receivables: A$10.40 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Radiopharm Theranostics Other Current Receivables?

Radiopharm Theranostics ASX:RAD Other Current Receivables is A$10.40 Mil as of Jun. 2025. The stock has 5 warning signs investors should review.

Radiopharm Theranostics's Other Current Receivables for the quarter that ended in Jun. 2025 was A$10.40 Mil.

Radiopharm Theranostics's quarterly Other Current Receivables increased from Jun. 2024 (A$0.99 Mil) to Dec. 2024 (A$1.62 Mil) and increased from Dec. 2024 (A$1.62 Mil) to Jun. 2025 (A$10.40 Mil).

Radiopharm Theranostics's annual Other Current Receivables declined from Jun. 2023 (A$4.36 Mil) to Jun. 2024 (A$0.99 Mil) but then increased from Jun. 2024 (A$0.99 Mil) to Jun. 2025 (A$10.40 Mil).

Radiopharm Theranostics Other Current Receivables Related Terms

Radiopharm Theranostics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Radiopharm Theranostics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radiopharm Theranostics Other Current Receivables Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Other Current Receivables
0.00 4.36 0.99 10.40

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Other Current Receivables Get a 7-Day Free Trial 4.36 0.00 0.99 1.62 10.40

Radiopharm Theranostics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of A$10.40 Mil mean?
Radiopharm Theranostics (ASX:RAD) has a Other Current Receivables of A$10.40 Mil as of Jun. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Radiopharm Theranostics and its competitors.
Is Radiopharm Theranostics' Other Current Receivables too high?
Radiopharm Theranostics' current Other Current Receivables is A$10.40 Mil.
How does Radiopharm Theranostics' Other Current Receivables compare to VRTX and REGN?
Radiopharm Theranostics' Other Current Receivables of A$10.40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Radiopharm Theranostics and its competitors. Radiopharm Theranostics's current Other Current Receivables is A$10.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiopharm Theranostics stock overvalued right now?
Radiopharm Theranostics (ASX:RAD) has a current Other Current Receivables of A$10.40 Mil. The current Other Current Receivables is A$10.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Radiopharm Theranostics (ASX:RAD), the current Other Current Receivables is A$10.40 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radiopharm Theranostics Business Description

Other Exchanges RADX:USA
Address 62 Lygon Street, Suite 1, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.